Cases & Deals

Pfizer acquires Coley Pharmaceutical Group, Inc. for a total value of $164 million

Clients Pfizer, Inc.

Jones Day represented Pfizer, Inc. in its acquisition of Coley Pharmaceutical Group, Inc. , a publicly-held biopharmaceutical company based in Wellesley, Massachusetts, specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.